Hyphens Pharma International Limited

Catalist:1J5 Stock Report

Market Cap: S$88.0m

Hyphens Pharma International Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Catalist:1J5 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Apr 24BuyS$17,875Kiat ChanIndividual65,000S$0.27
01 Apr 24BuyS$8,800Kia King TanIndividual32,000S$0.27
05 Mar 24BuyS$15,212Kiat ChanIndividual55,000S$0.28

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1J5?
Owner TypeNumber of SharesOwnership Percentage
Institutions5,407,3001.75%
General Public52,769,90017.1%
Individual Insiders103,043,35933.4%
Private Companies147,656,44147.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 16 shareholders own 82.92% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
47.8%
Inomed Holding Pte Ltd
147,656,441S$42.1m0%no data
28.1%
Kia King Tan
86,635,759S$24.7m0%no data
1.35%
Kian Peng Ng
4,172,900S$1.2m0%no data
1.3%
Nikko Asset Management Asia Limited
4,000,400S$1.1m0%0.05%
1.2%
Jui Fang Lau
3,719,800S$1.1m0%no data
0.53%
Eng Sai Ong
1,640,000S$467.4k0%no data
0.5%
Poh Lim Ong
1,535,600S$437.6k0%no data
0.46%
Ifast Financial Pte. Ltd., Asset Management Arm
1,406,900S$401.0k0%0.03%
0.36%
Yeow Hwee Lee
1,100,000S$313.5k0%no data
0.35%
Lee Wei Fang
1,087,200S$309.8k0%no data
0.35%
Poh Hwa Wong
1,072,000S$305.5k0%no data
0.22%
Yiew Hock Low
669,400S$190.8k0%no data
0.2%
Sew Lean Koh
607,000S$173.0k0%no data
0.19%
Yann Alain Marche
573,700S$163.5k0%no data
0.039%
Kiat Chan
120,000S$34.2k0%no data
0.036%
David Lim
110,000S$31.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 07:04
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hyphens Pharma International Limited is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David MakCGS International
Wee Kuang TayCGS International
Jiunn Chyuan TanKGI Securities Co. Ltd.